ARTICLE | Distillery Therapeutics
Cancer
March 13, 2018 5:41 PM UTC
Studies in patient samples, cell culture and mice suggest a miR-378a-3p variant or inhibiting its target PARVA could help treat melanoma. In patients, high tumor levels of PARVA were associated with p...
BCIQ Company Profiles
BCIQ Target Profiles